Merck & Co. has doubled down on its partnership with Variational AI, striking a deal worth up to $349 million to collaborate on small molecule candidates against two targets. Variational disclosed a ...
Shadow AI 2.0 isnβt a hypothetical future, itβs a predictable consequence of fast hardware, easy distribution, and developer ...
While precision seems critical for science, researchers from the U.S. Department of Energy's (DOE) Brookhaven National ...
Transforming drug discovery with generative AI Variational AI is using its Enki platform to explore uncharted regions of the chemical space, accelerating the discovery and development of ...
The advent of high-density recording technologies, such as Neuropixels and large-scale calcium imaging, has provided an unprecedented look into the ...
The collaboration operates within a fully transparent πππ¬π’π π§βπ¦ππ€πβπππ¬πβππ§ππ₯π²π³π (ππππ) framework that integrates AI-driven molecular design, rapid compound synthesis, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results